Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

CORR Insights®

Do Patients Live Longer After THA and Is the Relative Survival Diagnosis-specific?

Rüdiger, Hannes A.

Clinical Orthopaedics and Related Research®: June 2018 - Volume 476 - Issue 6 - p 1176–1177
doi: 10.1007/s11999.0000000000000191

H. A. Rüdiger, Department of Orthopaedics, Schulthess Clinic, Zürich, Switzerland

Hannes A Rüdiger MD, Schulthess Clinic Department of Orthopaedics Lengghalde 2 8008 Zürich, Switzerland Email:

This CORR Insights® is a commentary on the article “Do Patients Live Longer After THA and Is the Relative Survival Diagnosis-specific?” by Cnudde and colleagues available at: DOI: 10.1007/s11999.0000000000000097.

The author certifies that neither he, nor any members of his immediate family, have any commercial associations (such as consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.

The opinions expressed are those of the writers, and do not reflect the opinion or policy of CORR® or The Association of Bone and Joint Surgeons®.

This CORR Insights® comment refers to the article available at DOI: 10.1007/s11999.0000000000000097.

© 2018 Lippincott Williams & Wilkins LWW
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website